Download our Best Practice guidelines or watch a webinar to learn more about genomic testing excellence
Best Practice
The EMQN community is committed to educating genomic diagnostic service providers in providing the best possible service. We do this through regularly publishing best practice guidelines on the optimum way to test for and report on a wide range of specific diseases. We have adopted an internationally robust method of crafting our guidelines to ensure they are credible and comprehensive.
Watch our video to find out more.
Our guidelines below are freely available to view and download below.
- Genomic & inherited disorders
Developed by a consensus process using the 1998 CMGS guidelines as a starting point. We acknowledge the contribution of Dr David Rubinsztein to the 1998 CMGS guidelines.
- Genomic & inherited disorders
These guidelines were established at the EMQN Best Practice Meeting, held at 31st of October 2008 in Nijmegen, The Netherlands.
- Genomic & inherited disorders
The most noteworthy issue is that molecular analysis of the COL1A1/2 genes is recommended as the starting point in the diagnostic flow as opposed to protein analysis.
- Molecular Pathology
Funded by Eurogentest and by the UK Department of Health. EMQN contributed to this work.
- Genomic & inherited disorders
The BP meeting was organised by EMQN and supported by the EU Network of Excellence EuroGentest.
- Genomic & inherited disorders
Guidelines resulting from a conference held in Manchester, 25–26 October 2006, with the partnership of EuroGentest and the CF Network (www.cfnetwork.be).
- Genomic & inherited disorders
Developed by a consensus process using the 1998 CMGS guidelines as a starting point. We acknowledge the contribution of Dr David Rubinsztein to the 1998 CMGS guidelines.
- Genomic & inherited disorders
These guidelines were established at the EMQN Best Practice Meeting, held at 31st of October 2008 in Nijmegen, The Netherlands.
- Genomic & inherited disorders
The most noteworthy issue is that molecular analysis of the COL1A1/2 genes is recommended as the starting point in the diagnostic flow as opposed to protein analysis.
- Molecular Pathology
Funded by Eurogentest and by the UK Department of Health. EMQN contributed to this work.
- Genomic & inherited disorders
The BP meeting was organised by EMQN and supported by the EU Network of Excellence EuroGentest.
- Genomic & inherited disorders
Guidelines resulting from a conference held in Manchester, 25–26 October 2006, with the partnership of EuroGentest and the CF Network (www.cfnetwork.be).
Webinars
Educational
Playlist
4 Videos
EMQN support videos
Playlist
3 Videos
Individual Assessment of Classification of BRCA and HRR variants
Playlist
14 Videos
Ensuring accurate classification of BRCA1, BRCA2 and HRR gene variants - Run 11 (November 15 2023)
1:24:19
Virtual Educational Masterclass: Accurate Variant Classification and Clinical Impact of Variability
1:31:01
Lessons learned: 2022 EQA scheme for BRCA and other HRR gene variants in ovarian and prostate cancer
1:08:00
Ensuring accurate classification of variants in BRCA1/BRCA2/HRR genes - March 15 2023 - Run 10 Web 1
1:27:05
Ensuring Accurate Classification of BRCA and HRR Variants - 10th December 2020 (Run 5, Webinar 2)
51:57
Ensuring Accurate Classification BRCA1, BRCA2 and HRR Gene Variants - 20 July 2022 (Run 8 Webinar 2)
1:03:05
Ensuring Accurate Classification BRCA1, BRCA2 and HRR Gene Variants - 7 June 2022 (Run 8 Webinar 1)
1:11:49
Thought leadership
We also offer a range of other materials to assist you in improving your testing and reporting capabilities.
Calendar
Click on links below to download the calendars for 2022 and 2023 (last updated 16/09/2022)
